The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Regulatory Alert: FDA's April 2026 Update on BPC 157 and GHK Cu Holt Law FDA to weigh easing limits on peptides promoted by RFK Jr. NBC 6 South Florida FDA to weigh easing limits on unproven peptides favored by RFK Jr. and MAHA supporters PBS News The peptide problem: Hype is outrunning the evidence A closer look at the unapproved peptide injections promoted by influencers and celebrities king5.com